Evidence map›Paper›PMID 25490422›Full record

ArticleNanomedicine (London, England)2014

Challenges and opportunities in developing nanoparticles for detoxification.

Xin Qu, Maling Gou, Jana Zaidan, Kang Zhang, Shaochen Chen

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomedicine (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. A Hepatocyte-Mimicking Antidote for Alcohol Intoxication.Advanced materials (Deerfield Beach, Fla.) · 2018
    Article
  4. A biomimetic nanoparticle-enabled toxoid vaccine against melittin.International journal of nanomedicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xin Qu *Department of NanoEngineering, University of California, San Diego, La Jolla, CA 92093, USA.
Maling Gou *State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Jana ZaidanDepartment of NanoEngineering, University of California, San Diego, La Jolla, CA 92093, USA.
Kang ZhangShiley Eye Center, University of California, San Diego, La Jolla, CA 92093, USA and Biomaterials & Tissue Engineering Center, University of California, San Diego, La Jolla, CA 92093, USA.
Shaochen ChenDepartment of NanoEngineering, University of California, San Diego, La Jolla, CA 92093, USA and Biomaterials & Tissue Engineering Center, University of California, San Diego, La Jolla, CA 92093, USA.

Funding

Reducing STIs in Emerging Adults Who Use Alcohol and MarijuanaR01AA020509 · NIAAA · BUTLER HOSPITAL (PROVIDENCE, RI) · PI STEIN, MICHAEL D · 2011 to 2015
$2.7M
A Microfabrication Platform for Direct Printing Vascularized Functional Tissue CoR01EB012597 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, SHAOCHEN · 2010 to 2013
$1.4M
Biomimetic design of human induced pluripotent stem cells on a chipR21EB017876 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHEN, SHAOCHEN · 2013 to 2014
$419k
NIAAA NIH HHS R01 AA020509NIBIB NIH HHS EB012597NIBIB NIH HHS EB017876NIBIB NIH HHS R01 EB012597NIBIB NIH HHS R21 EB017876
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Inactivation, MetabolicNanomedicineHumansNanoparticles3D printingdetoxificationnanomedicinenanoparticlespolymer

Identifiers

PMID25490422
PMCPMC4435740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.